KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EPS (Weighted Average and Diluted) (2016 - 2025)

LifeMD's EPS (Weighted Average and Diluted) history spans 12 years, with the latest figure at -$0.12 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 33.33% year-over-year to -$0.12; the TTM value through Dec 2025 reached -$0.3, up 56.52%, while the annual FY2025 figure was -$0.3, 53.12% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.12 in Q4 2025 per LFMD's latest filing, down from -$0.1 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.03 in Q1 2025 to a low of -$0.64 in Q2 2021.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.28, with a median of -$0.2 recorded in 2023.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 137.04% in 2021, then skyrocketed 84.21% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.63 in 2021, then skyrocketed by 36.51% to -$0.4 in 2022, then skyrocketed by 70.0% to -$0.12 in 2023, then crashed by 50.0% to -$0.18 in 2024, then soared by 33.33% to -$0.12 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's EPS (Weighted Average and Diluted) are -$0.12 (Q4 2025), -$0.1 (Q3 2025), and -$0.05 (Q2 2025).